https://9krapalm.com/j-ints-bio-presents-interim-findings-from-phase-1-2-clinical-trial-of-4th-generation-egfr-tki-jin-a02-in-nsclc-a-potential-breakthrough-in-overcoming-acquired-resistance-to-targeted-therapy/ เสิร์ฟข่าวไอที อัปเดตเทคโนโลยีสไตล์ @krapalm Thu, 24 Oct 2024 05:49:41 +0000 hourly 1 https://wordpress.org/?v=7.0